Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A real world retrospective study to assess practice patterns and outcomes around vasoconstrictor use for hepatorenal syndrome in UK hospitals

Next Previous
Trial Profile

A real world retrospective study to assess practice patterns and outcomes around vasoconstrictor use for hepatorenal syndrome in UK hospitals

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Terlipressin (Primary) ; Albumins; Vasopressors
  • Indications Hepatorenal syndrome
  • Focus Therapeutic Use

Most Recent Events

  • 08 Nov 2022 Results assessing real-world patient characteristics, treatment patterns, and outcomes for hospitalized HRS patients from two medical chart studies in United Kingdom and United States, presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases.
  • 27 Oct 2021 Results of post-hoc analysis assessing the efficacy and safety outcomes in patients with an SCr > 5 mg/dL at the time of vasopressor initiation, presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021.
  • 29 Aug 2020 Results presented at The International Liver Congress 2020

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top